BioAge Labs, Inc. Common Stock

BIOANASDAQ • USD
ThemeLongevity & Aging›Age-Related Therapeutics
22.81 USD
↗ 0.65 (2.93%)AT CLOSE (11:59 AM EDT)
22.25
↘ 0.56 (2.48%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
22.25
↘ 0.56 (2.48%)
🔴Market: CLOSED

Shares of BioAge Labs, Inc. Common Stock (BIOA) are trading at $22.79. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, BIOA trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jul 17, 2026.

Open?$21.36
High?$23.49
Low?$21.36
Prev. Close?$22.16
Volume?458.7K
Avg. Volume?632.5K
VWAP?$22.98
Rel. Volume?0.73x
Bid / Ask
Bid?$16.77 × 100
Ask?$27.05 × 100
Spread?$10.28
Midpoint?$21.91
Valuation & Ratios
Market Cap?985.1M
Shares Out?44.5M
Float?31.5M
Float %?70.9%
P/E Ratio?N/A
P/B Ratio?2.60
EPS?-$2.02
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Themes
Longevity & Aging›Age-Related TherapeuticsBiotech - Drug Development›Metabolic & Cardiometabolic
Employees
62
Market Cap
985.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.bioagelabs.com
Listed
2024-09-26
Address
5885 HOLLIS STREET
EMERYVILLE, CA 94608
Phone: 510-806-1445
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
57
Short Sent.?
30
Piotroski F-Score?0/9Weak
Altman Z-Score?30.96Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.88%High
Short Interest?3.7M
Days to Cover?4.0
Free Float31.5M
Avg Daily Volume932.9K
Settlement Date2026-06-30
Financial Health
Current Ratio?24.76Strong
Quick Ratio?24.76Strong
Cash Ratio?15.28Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
62
2.60CHEAP▾
P/S?
Peers
100
S&P
3
95.49HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-7.3CHEAP▾
EV/Sales?
Peers
100
S&P
3
72.17HIGH▾
Returns & Efficiency
ROE?
S&P
7
-23.7%WEAK▾
ROA?
S&P
3
-22.6%WEAK▾
Cash Flow & Enterprise
FCF?$-88629000
Enterprise Value?$744.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist